CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i
COVID-19 state of vaccine confidence insights report ; report 14, September 13, 2021
-
September 13, 2021
-
[PDF-969.45 KB]
Details:
-
Corporate Authors:
-
Description:Date Range: August 17 – 30, 2021
Summary
Findings. The announcement of the Food and Drug Administration's first full approval of a COVID-19 vaccine, Pfizer-BioNTech vaccine/Comirnaty, drove conversations in the news and on social media about the future of vaccine mandates. Consumers remain divided over whether vaccine mandates should be implemented and if natural immunity should be considered. Conversations online about the use of ivermectin to treat and prevent COVID-19 entered public consciousness with many consumers looking for more information online about whether the medication would work and how to get it. Some consumers claimed that ivermectin was safer and more effective than available vaccines. Several consumers, both for and against ivermectin, also felt that ivermectin use and promotion by other consumers and vocal vaccine deniers was a manifestation of the lack of trust in the United States government in handling the COVID-19 pandemic. Lastly, consumer interest in vaccinating children under 12 years old increased as students prepared or returned to school in August. Parents expressed confusion about the risk of COVID-19 to their children and were divided about whether to vaccinate their child or adolescent.
Ways to take action. Federal, state, and local partners should continue to work together to explain the rationale for updated guidance, respond to gaps in information, and confront misinformation with evidence-based messaging. The goal of these efforts is to increase confidence in COVID-19 vaccines and expand vaccine uptake more broadly. Messages leveraging available safety and effectiveness data should be tailored for a variety of demographics and disseminated by partnering with trusted messengers and healthcare personnel to further amplify these messages. Research should be supported to better understand the impact of authorized or approved treatments of vaccination intent and the motivation and interest in vaccination among adolescents and children.CS000000-A | 09/13/21
SoVC-report14.pdf
-
Subjects:
-
Series:
-
Document Type:
-
Pages in Document:8 numbered pages
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
